Sahena Haque

767 total citations
19 papers, 346 citations indexed

About

Sahena Haque is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Sahena Haque has authored 19 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 8 papers in Immunology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Sahena Haque's work include Systemic Lupus Erythematosus Research (11 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Systemic Sclerosis and Related Diseases (5 papers). Sahena Haque is often cited by papers focused on Systemic Lupus Erythematosus Research (11 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Systemic Sclerosis and Related Diseases (5 papers). Sahena Haque collaborates with scholars based in United Kingdom, United States and Canada. Sahena Haque's co-authors include Ian N Bruce, M. Yvonne Alexander, John A. Reynolds, Kate Williamson, David Ray, Pauline Ho, Rachel Gorodkin, Neil Snowden, Eoghan McCarthy and Ben Parker and has published in prestigious journals such as Scientific Reports, Annals of the Rheumatic Diseases and Quality of Life Research.

In The Last Decade

Sahena Haque

18 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sahena Haque United Kingdom 11 219 171 55 48 47 19 346
DD Gladman Canada 12 290 1.3× 192 1.1× 49 0.9× 42 0.9× 23 0.5× 19 341
Weng Giap Law Singapore 11 331 1.5× 180 1.1× 110 2.0× 47 1.0× 23 0.5× 16 429
С. И. Глухова Russia 8 205 0.9× 106 0.6× 38 0.7× 22 0.5× 39 0.8× 149 316
Jonathan H. Chung United States 9 123 0.6× 265 1.5× 51 0.9× 58 1.2× 71 1.5× 18 478
Alper M. van Sijl Netherlands 14 460 2.1× 121 0.7× 34 0.6× 111 2.3× 86 1.8× 24 585
T Y Lian Singapore 7 396 1.8× 223 1.3× 83 1.5× 47 1.0× 14 0.3× 13 459
Steven Young‐Min United Kingdom 7 163 0.7× 48 0.3× 62 1.1× 20 0.4× 58 1.2× 13 356
Marie Godfrin-Valnet France 12 322 1.5× 119 0.7× 32 0.6× 13 0.3× 48 1.0× 21 433
Tina Mahajan United States 9 288 1.3× 161 0.9× 51 0.9× 14 0.3× 41 0.9× 11 430
Stylianos Karvounaris Greece 7 319 1.5× 111 0.6× 22 0.4× 43 0.9× 97 2.1× 10 488

Countries citing papers authored by Sahena Haque

Since Specialization
Citations

This map shows the geographic impact of Sahena Haque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sahena Haque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sahena Haque more than expected).

Fields of papers citing papers by Sahena Haque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sahena Haque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sahena Haque. The network helps show where Sahena Haque may publish in the future.

Co-authorship network of co-authors of Sahena Haque

This figure shows the co-authorship network connecting the top 25 collaborators of Sahena Haque. A scholar is included among the top collaborators of Sahena Haque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sahena Haque. Sahena Haque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Haque, Sahena, et al.. (2025). Oral ulcer in systemic lupus erythematosus: a case of methotrexate-induced Epstein–Barr virus infection. Rheumatology Advances in Practice. 9(2). rkaf042–rkaf042.
2.
Reynolds, John A., Ariane L. Herrick, Sahena Haque, et al.. (2024). Clinical trial eligibility of a real-world connective tissue disease cohort: Results from the LEAP cohort. Seminars in Arthritis and Rheumatism. 67. 152463–152463. 1 indexed citations
3.
Reynolds, John A., Ariane L. Herrick, Sahena Haque, et al.. (2022). Determinants of health-related quality of life across the spectrum of connective tissue diseases using latent profile analysis: results from the LEAP cohort. Lara D. Veeken. 62(8). 2673–2682. 4 indexed citations
4.
Reynolds, John A., Tracy A. Briggs, Gillian Rice, et al.. (2019). Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles. Arthritis Research & Therapy. 21(1). 147–147. 19 indexed citations
5.
Oldroyd, Alexander, et al.. (2019). AB0593 INTERSTITIAL LUNG DISEASE ASSOCIATED WITH ANCA POSITIVITY: A RETROSPECTIVE ANALYSIS. Annals of the Rheumatic Diseases. 78. 1757–1758. 1 indexed citations
6.
Haque, Sahena, et al.. (2019). Interstitial lung disease associated with ANCA positivity: a retrospective analysis. PA1362–PA1362. 2 indexed citations
7.
Reynolds, John A., Eoghan McCarthy, Sahena Haque, et al.. (2018). Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations. Arthritis Research & Therapy. 20(1). 173–173. 45 indexed citations
8.
Haque, Sahena, Sarah Skeoch, Yasmeen Ahmad, et al.. (2018). Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: the role of classic and SLE-related factors. Lupus Science & Medicine. 5(1). e000267–e000267. 21 indexed citations
9.
Shaw, Steven M., et al.. (2017). Certolizumab Pegol–Induced Heart Failure. JCR Journal of Clinical Rheumatology. 24(1). 55–56. 5 indexed citations
10.
Reynolds, John A., Sahena Haque, Kate Williamson, et al.. (2016). Vitamin D improves endothelial dysfunction and restores myeloid angiogenic cell function via reduced CXCL-10 expression in systemic lupus erythematosus. Scientific Reports. 6(1). 22341–22341. 51 indexed citations
11.
Meacock, Rachel, Mark Harrison, Kathleen McElhone, et al.. (2014). Mapping the disease-specific LupusQoL to the SF-6D. Quality of Life Research. 24(7). 1749–1758. 9 indexed citations
12.
Haque, Sahena, Pauline Ho, Rachel Gorodkin, et al.. (2013). Brief Report: Shortened Telomere Length in Patients With Systemic Lupus Erythematosus. Arthritis & Rheumatism. 65(5). 1319–1323. 36 indexed citations
13.
Chew, Christine, et al.. (2013). Serum cystatin C is independently associated with renal impairment and high sensitivity C-reactive protein in systemic lupus erythematosus.. PubMed. 31(2). 251–5. 15 indexed citations
14.
Haque, Sahena, M. Yvonne Alexander, & Ian N Bruce. (2012). Endothelial progenitor cells: a new player in lupus?. Arthritis Research & Therapy. 14(1). 203–203. 16 indexed citations
15.
Haque, Sahena, et al.. (2012). Limited End-User Knowledge of Methotrexate Despite Patient Education. JCR Journal of Clinical Rheumatology. 18(3). 130–133. 10 indexed citations
16.
Harrison, Mark, Yasmeen Ahmad, Sahena Haque, et al.. (2012). Construct and Criterion Validity of the Short Form-6D Utility Measure in Patients with Systemic Lupus Erythematosus. The Journal of Rheumatology. 39(4). 735–742. 14 indexed citations
17.
Haque, Sahena, et al.. (2008). Romatoid artrit ve sistemik lupus eritematozusda ateroskleroz. Current Opinion in Lipidology. 3(4). 192–199. 1 indexed citations
18.
Haque, Sahena, et al.. (2008). Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Current Opinion in Lipidology. 19(4). 338–343. 45 indexed citations
19.
Haque, Sahena & Ian N Bruce. (2005). Therapy Insight: systemic lupus erythematosus as a risk factor for cardiovascular disease. Nature Clinical Practice Cardiovascular Medicine. 2(8). 423–430. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by DD Gladman Breakdown of academic impact, for papers by Weng Giap Law Breakdown of academic impact, for papers by С. И. Глухова Breakdown of academic impact, for papers by Jonathan H. Chung Breakdown of academic impact, for papers by Alper M. van Sijl Breakdown of academic impact, for papers by T Y Lian Breakdown of academic impact, for papers by Steven Young‐Min Breakdown of academic impact, for papers by Marie Godfrin-Valnet Breakdown of academic impact, for papers by Tina Mahajan Breakdown of academic impact, for papers by Stylianos Karvounaris
Rankless by CCL
2026